[1] Yu Y H,Lian Z Q.Update on transfusion-related acute lung injury: an overview of its pathogenesis and management[J]. Front Immunol,2023,14:1175387. [2] 《输血相关急性肺损伤诊治中国专家共识》编写组. 输血相关急性肺损伤诊治中国专家共识(2023版)[J]. 临床输血与检验,2023,25(5):577-585. [3] Vlaar A P,Juffermans N P.Transfusion-related acute lung injury: a clinical review[J]. Lancet,2013,382(9896): 984-994. [4] Théry C,Witwer K W,Aikawa E,et al.Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines[J]. J Extracell Vesicles,2018, 7(1):1535750. [5] Sengupta V,Sengupta S,Lazo A,et al.Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19[J]. Stem Cells Dev,2020,29(12): 747-754. [6] Sun J,Yang Y M,Huo X N,et al.Efficient therapeutic function and mechanisms of human polyclonal CD8+CD103+Foxp3+Regulatory T cells on collagen-induced arthritis in mice[J]. J Immunol Res,2019,2019: 8575407. [7] Looney M R,Nguyen J X,Hu Y M,et al.Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury[J]. J Clin Invest,2009,119(11):3450-3461. [8] 高跞,杨懿铭,蒋雪玉,等. 输注异基因耐受性DC产生的外囊泡体引发输血相关急性肺损伤风险的研究[J]. 临床输血与检验,2024,26(5):592-597. [9] Robbins P D,Morelli A E.Regulation of immune responses by extracellular vesicles[J]. Nat Rev Immunol, 2014,14(3):195-208. [10] Balaj L,Lessard R,Dai L X,et al.Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences[J]. Nat Commun,2011,2:180. [11] Wei X X,Yi X M,Lv H J,et al.microRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy[J]. Cell Death Dis,2020,11(8):657. [12] Buzas E I.The roles of extracellular vesicles in the immune system[J]. Nat Rev Immunol,2023,23(4):236-250. [13] Théry C,Louvard D.The roles and applications of extracellular vesicles in cancer[J]. Mol Oncol,2025, 19(5):1287-1290. [14] Liu C,Xiao K,Xie L X.Advances in the use of exosomes for the treatment of ALI/ARDS[J]. Front Immunol,2022, 13:971189. [15] Tung J P,Chiaretti S,Dean M M,et al.Transfusion-related acute lung injury (TRALI): Potential pathways of development,strategies for prevention and treatment, and future research directions[J]. Blood Rev,2022,53: 100926. [16] Wyman T H,Bjornsen A J,Elzi D J,et al.A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release[J]. Am J Physiol Cell Physiol,2002,283(6):C1592-C1603. [17] Xie R F,Hu P,Wang Z C,et al.Platelet-derived microparticles induce polymorphonuclear leukocyte-mediated damage of human pulmonary microvascular endothelial cells[J]. Transfusion,2015,55(5):1051-1057. [18] Kuebler W M,William N,Post M,et al.Extracellular vesicles: effectors of transfusion-related acute lung injury[J]. Am J Physiol Lung Cell Mol Physiol,2023, 325(3):L327-L341. |